TY - JOUR
T1 - Effects of HI-6 and pralidoxime on neuronal RNA in thalamic cholinergic sites
AU - Martin, Lee J.
AU - Doebler, Jeffrey A.
AU - Anthony, Adam
N1 - Funding Information:
Send all correspondence: Dr. Adam Anthony, Professor of Biology, 418 Mueller Laboratory, University Park, PA 16802, U.S.A. Tel. (814)865-4031. This research was supported in part by USAMRDC contract 17-81-C-1202.
Copyright:
Copyright 2014 Elsevier B.V., All rights reserved.
PY - 1985/11
Y1 - 1985/11
N2 - Quantitative azure B-RNA cytophotometry was employed to compare effects of the oximes HI-6 and pralidoxime (2-PAM) to those of atropine sulfate (AS) on neruronal RNA metabolism in the thalamic ventrobasal nuclear complex (VBC) and nucleus reticularis (NR). The ability of these compounds to mitigate soman (pinacolyl methylphosphonofluoridate)-induced neuronal RNA alterations (i.e., VBC-RNA depletion/NR-RNA elevation) in these muscarinic cholinergic sites was also determined. Generally, HI-6 (125 mg/kg, i.p.) and 2-PAM (43.2 mg/kg, i.m.) elicited similar patterns of neuronal RNA changes, i.e., diminution of VBC-RNA and NR-RNA with oximes alone; partial amelioration of soman (1.5 LD50, s.c.)-induced VBC-RNA loss; and slight or no effect on soman induced NR-RNA accumulation. HI-6 produced more severe RNA reduction than 2-PAM in both brain regions of non-poisoned rats, whereas 2-PAM was more effective in reversing the effects of soman in these two regions. The muscarinic antagonist, AS, also produced VBC-RNA depletion and partially counteracted the VBC-RNA loss in soman intoxicated rats. Unlike the oximes, however, AS resulted in NR-RNA accumulation and it also antagonized soman induced NR-RNA elevation. Neither oxime reactivated soman inhibited brain acetylcholinesterase but HI-6 did reactivate appreciable plasma cholinesterase. The overall data suggest that HI-6 and 2-PAM do exert pharmacologic actions on cholinergic neurons in the rat CNS. However, the greater effectiveness of HI-6 over 2-PAM in countering lethal actions of soman does not appear to be correlated with oxime mediated restoration of neuronal RNA levels in these two cholinergic regions. Thus, not central cholinergic actions, but peripheral effects of oximes, such as cholinesterase reactivation, may be crucial for antidotal protection.
AB - Quantitative azure B-RNA cytophotometry was employed to compare effects of the oximes HI-6 and pralidoxime (2-PAM) to those of atropine sulfate (AS) on neruronal RNA metabolism in the thalamic ventrobasal nuclear complex (VBC) and nucleus reticularis (NR). The ability of these compounds to mitigate soman (pinacolyl methylphosphonofluoridate)-induced neuronal RNA alterations (i.e., VBC-RNA depletion/NR-RNA elevation) in these muscarinic cholinergic sites was also determined. Generally, HI-6 (125 mg/kg, i.p.) and 2-PAM (43.2 mg/kg, i.m.) elicited similar patterns of neuronal RNA changes, i.e., diminution of VBC-RNA and NR-RNA with oximes alone; partial amelioration of soman (1.5 LD50, s.c.)-induced VBC-RNA loss; and slight or no effect on soman induced NR-RNA accumulation. HI-6 produced more severe RNA reduction than 2-PAM in both brain regions of non-poisoned rats, whereas 2-PAM was more effective in reversing the effects of soman in these two regions. The muscarinic antagonist, AS, also produced VBC-RNA depletion and partially counteracted the VBC-RNA loss in soman intoxicated rats. Unlike the oximes, however, AS resulted in NR-RNA accumulation and it also antagonized soman induced NR-RNA elevation. Neither oxime reactivated soman inhibited brain acetylcholinesterase but HI-6 did reactivate appreciable plasma cholinesterase. The overall data suggest that HI-6 and 2-PAM do exert pharmacologic actions on cholinergic neurons in the rat CNS. However, the greater effectiveness of HI-6 over 2-PAM in countering lethal actions of soman does not appear to be correlated with oxime mediated restoration of neuronal RNA levels in these two cholinergic regions. Thus, not central cholinergic actions, but peripheral effects of oximes, such as cholinesterase reactivation, may be crucial for antidotal protection.
KW - Atropine
KW - HI-6
KW - Organophosphate acetylcholinesterase inhibitors
KW - Oxime acetylcholine reactivators
KW - Pralidoxime
KW - Quantitative RNA cytophotometry
KW - Soman
KW - Thalamic cholinergic sites
UR - http://www.scopus.com/inward/record.url?scp=0022342228&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022342228&partnerID=8YFLogxK
U2 - 10.1016/0022-510X(85)90032-2
DO - 10.1016/0022-510X(85)90032-2
M3 - Article
C2 - 2418157
AN - SCOPUS:0022342228
SN - 0022-510X
VL - 71
SP - 1
EP - 8
JO - Journal of the Neurological Sciences
JF - Journal of the Neurological Sciences
IS - 1
ER -